The use of human papillomavirus testing to monitor effectiveness of treatment of high-grade intraepithelial abnormalities of the cervix
Medical Services Advisory Committee
Record ID 32005001122
English
Authors' objectives:
This report summarises the assessment of current evidence for the use of human papillomavirus (HPV) testing by hybrid capture II (HC-II) or polymerase chain reaction (PCR) at 12 and 24 months to monitor the effectiveness of treatment of high-grade squamous intraepithelial lesions of the cervix.
Authors' recommendations:
MSAC recommended that on the strength of evidence pertaining to the use of high-risk HPV testing (HC-II or PCR) at 12 and 24 months following treatment of high-grade squamous intraepithelial lesions of the cervix to monitor the effectiveness of treatment, public funding should be supported for this procedure.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au/pdfs/reports/msacref12e.pdf
Year Published:
2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Costs and Cost Analysis
- Vaginal Smears
- Carcinoma
- Papillomavirus Infections
- Tumor Virus Infections
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.